BioLife Solns Q2 2024 Adj. EPS $(0.05) Beats $(0.14) Estimate, Sales $28.328M Beat $23.946M Estimate
Author: Benzinga Newsdesk | August 08, 2024 04:57pm
BioLife Solns (NASDAQ:
BLFS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.14) by 64.29 percent. This is a 61.54 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $28.328 million which beat the analyst consensus estimate of $23.946 million by 18.30 percent. This is a 3.11 percent decrease over sales of $29.237 million the same period last year.
Posted In: BLFS